Last reviewed · How we verify
AV45
At a glance
| Generic name | AV45 |
|---|---|
| Sponsor | Chang Gung Memorial Hospital |
| Modality | Small molecule |
| Therapeutic area | Other |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Longitudinal Early-onset Alzheimer's Disease Study Protocol
- Pan-Amyloid PET/CT in Various Amyloid-Related Disease
- Aβ PET and Tau PET Imaging in the Diagnosis and Progression Assessment of Alzheimer's Disease (NA)
- Clinical Applicantion of Multi-Tracer PET/MR Imaging in Neurological Disorders/Disease
- Beta Amyloid PET/CT in Various Aβ-Related Disease
- Effects of Brain Beta-Amyloid on Postoperative Cognition (PHASE4)
- Distinguishing Between Alzheimer's Disease, Lewy Body Dementia, and Parkinson's Disease
- Autopsy Follow-up of Subjects Previously Imaged With Florbetapir F 18 (18F-AV-45) PET in Trial 18F-AV-45-A07 (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |